Suppr超能文献

骨骼肌阻力小动脉反应性在代谢综合征灌注反应中的整合

Integration of skeletal muscle resistance arteriolar reactivity for perfusion responses in the metabolic syndrome.

作者信息

Frisbee Jefferson C, Hollander John M, Brock Robert W, Yu Han-Gang, Boegehold Matthew A

机构信息

Center for Cardiovascular and Respiratory Sciences, Department of Physiology and Pharmacology, PO Box 9105, West Virginia University School of Medicine, Morgantown, WV 26505, USA.

出版信息

Am J Physiol Regul Integr Comp Physiol. 2009 Jun;296(6):R1771-82. doi: 10.1152/ajpregu.00096.2009. Epub 2009 Apr 22.

Abstract

Previous study suggests that with evolution of the metabolic syndrome, patterns of arteriolar reactivity are profoundly altered and may constrain functional hyperemia. This study investigated interactions between parameters of vascular reactivity at two levels of resistance arterioles in obese Zucker rats (OZR), translating these observations into perfusion regulation for in situ skeletal muscle. Dilation of isolated and in situ resistance arterioles from OZR to acetylcholine, arachidonic acid (AA), and hypoxia (isolated arterioles only) were blunted vs. lean Zucker rats (LZR), although dilation to adenosine was intact. Increased adrenergic tone (phenylephrine) or intralumenal pressure (ILP) impaired dilation in both strains (OZR>LZR). Treatment of OZR arterioles with Tempol (superoxide dismutase mimetic) or SQ-29548 (prostaglandin H2/thromboxane A2 receptor antagonist) improved dilator reactivity under control conditions and with increased ILP, but had minimal effect with increased adrenergic tone. Arteriolar dilation to adenosine was well maintained in both strains under all conditions. For in situ cremasteric arterioles, muscle contraction-induced elevations in metabolic demand elicited arteriolar dilations and hyperemic responses that were blunted in OZR vs. LZR, although distal parallel arterioles were characterized by heterogeneous dilator and perfusion responses. alpha-Adrenoreceptor blockade improved outcomes at rest but had minimal effect with elevated metabolic demand. Treatment with Tempol or SQ-29548 had minimal impact at rest, but lessened distal arteriolar perfusion heterogeneity with increased metabolic demand. In blood-perfused gastrocnemius of OZR, perfusion was constrained primarily by adrenergic tone, while myogenic activation and endothelium-dependent dilation did not appear to contribute significantly to ischemia. These results of this novel, integrated approach suggest that adrenergic tone and metabolic dilation are robust determinants of bulk perfusion to skeletal muscle of OZR, while endothelial dysfunction may more strongly regulate perfusion distribution homogeneity via the impact of oxidant stress and AA metabolism.

摘要

先前的研究表明,随着代谢综合征的演变,小动脉反应模式会发生深刻改变,并可能限制功能性充血。本研究调查了肥胖 Zucker 大鼠(OZR)中两个阻力小动脉水平的血管反应参数之间的相互作用,并将这些观察结果转化为原位骨骼肌的灌注调节。与瘦 Zucker 大鼠(LZR)相比,OZR 的离体和原位阻力小动脉对乙酰胆碱、花生四烯酸(AA)和缺氧(仅离体小动脉)的舒张反应减弱,尽管对腺苷的舒张反应正常。增加肾上腺素能张力(去氧肾上腺素)或管腔内压力(ILP)会损害两种品系的舒张反应(OZR>LZR)。用 Tempol(超氧化物歧化酶模拟物)或 SQ-29548(前列腺素 H2/血栓素 A2 受体拮抗剂)处理 OZR 小动脉可改善对照条件下和 ILP 增加时的舒张反应性,但对肾上腺素能张力增加的影响最小。在所有条件下两种品系对腺苷的小动脉舒张反应均保持良好。对于原位提睾肌小动脉,肌肉收缩引起的代谢需求升高引发小动脉舒张和充血反应,但 OZR 中的反应比 LZR 减弱,尽管远端平行小动脉的特征是舒张和灌注反应不均一。α-肾上腺素受体阻断改善了静息状态下的结果,但对代谢需求升高的影响最小。用 Tempol 或 SQ-29548 处理在静息时影响最小,但随着代谢需求增加减少了远端小动脉灌注的不均一性。在 OZR 的血液灌注腓肠肌中灌注主要受肾上腺素能张力限制,而肌源性激活和内皮依赖性舒张似乎对缺血没有显著贡献。这种新颖的综合方法得出的这些结果表明,肾上腺素能张力和代谢性舒张是 OZR 骨骼肌总体灌注的有力决定因素,而内皮功能障碍可能通过氧化应激和 AA 代谢的影响更强烈地调节灌注分布均一性

相似文献

1
Integration of skeletal muscle resistance arteriolar reactivity for perfusion responses in the metabolic syndrome.
Am J Physiol Regul Integr Comp Physiol. 2009 Jun;296(6):R1771-82. doi: 10.1152/ajpregu.00096.2009. Epub 2009 Apr 22.
2
Enhanced arteriolar alpha-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats.
J Appl Physiol (1985). 2004 Aug;97(2):764-72. doi: 10.1152/japplphysiol.01216.2003. Epub 2004 Apr 9.
3
Vascular adrenergic tone and structural narrowing constrain reactive hyperemia in skeletal muscle of obese Zucker rats.
Am J Physiol Heart Circ Physiol. 2006 May;290(5):H2066-74. doi: 10.1152/ajpheart.01251.2005. Epub 2005 Dec 22.
4
Impaired hemorrhage tolerance in the obese Zucker rat model of metabolic syndrome.
J Appl Physiol (1985). 2006 Feb;100(2):465-73. doi: 10.1152/japplphysiol.01062.2005. Epub 2005 Oct 13.
5
Impaired skeletal muscle perfusion in obese Zucker rats.
Am J Physiol Regul Integr Comp Physiol. 2003 Nov;285(5):R1124-34. doi: 10.1152/ajpregu.00239.2003. Epub 2003 Jul 10.
6
Altered post-capillary and collecting venular reactivity in skeletal muscle with metabolic syndrome.
J Physiol. 2017 Aug 1;595(15):5159-5174. doi: 10.1113/JP274291. Epub 2017 Jul 5.
7
Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome.
Am J Physiol Regul Integr Comp Physiol. 2005 Aug;289(2):R307-R316. doi: 10.1152/ajpregu.00114.2005. Epub 2005 Mar 31.
8
Remodeling of the skeletal muscle microcirculation increases resistance to perfusion in obese Zucker rats.
Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H104-11. doi: 10.1152/ajpheart.00118.2003. Epub 2003 Mar 20.
9
Type 2 diabetes mellitus in the Goto-Kakizaki rat impairs microvascular function and contributes to premature skeletal muscle fatigue.
J Appl Physiol (1985). 2019 Mar 1;126(3):626-637. doi: 10.1152/japplphysiol.00751.2018. Epub 2018 Dec 20.
10
Divergence between arterial perfusion and fatigue resistance in skeletal muscle in the metabolic syndrome.
Exp Physiol. 2011 Mar;96(3):369-83. doi: 10.1113/expphysiol.2010.055418. Epub 2010 Dec 1.

引用本文的文献

3
Nitrosative stress uncovers potent β-adrenergic receptor-linked vasodilation further enhanced by blockade of clathrin endosome formation.
Am J Physiol Heart Circ Physiol. 2018 Jun 1;314(6):H1298-H1308. doi: 10.1152/ajpheart.00365.2017. Epub 2018 Mar 23.
4
Increased peripheral vascular disease risk progressively constrains perfusion adaptability in the skeletal muscle microcirculation.
Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H488-504. doi: 10.1152/ajpheart.00790.2015. Epub 2015 Dec 23.
5
Regional variation in arterial stiffening and dysfunction in Western diet-induced obesity.
Am J Physiol Heart Circ Physiol. 2015 Aug 15;309(4):H574-82. doi: 10.1152/ajpheart.00155.2015. Epub 2015 Jun 19.
6
Modulation of endothelial cell phenotype by physical activity: impact on obesity-related endothelial dysfunction.
Am J Physiol Heart Circ Physiol. 2015 Jul 1;309(1):H1-8. doi: 10.1152/ajpheart.00177.2015. Epub 2015 May 1.
7
Microvascular perfusion heterogeneity contributes to peripheral vascular disease in metabolic syndrome.
J Physiol. 2016 Apr 15;594(8):2233-43. doi: 10.1113/jphysiol.2014.285247. Epub 2014 Dec 18.
8
Exercise-mediated vasodilation in human obesity and metabolic syndrome: effect of acute ascorbic acid infusion.
Am J Physiol Heart Circ Physiol. 2014 Sep 15;307(6):H840-7. doi: 10.1152/ajpheart.00312.2014. Epub 2014 Jul 18.
9
Impaired dopamine D1 receptor-mediated vasorelaxation of mesenteric arteries in obese Zucker rats.
Cardiovasc Diabetol. 2014 Feb 22;13:50. doi: 10.1186/1475-2840-13-50.

本文引用的文献

1
Obesity and the metabolic syndrome in developing countries.
J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S9-30. doi: 10.1210/jc.2008-1595.
2
Epidemiology of obesity in the Western Hemisphere.
J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S1-8. doi: 10.1210/jc.2008-1356.
3
Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease.
Am Heart J. 2008 Oct;156(4):719-27. doi: 10.1016/j.ahj.2008.05.020. Epub 2008 Jul 11.
4
Depression: an important comorbidity with metabolic syndrome in a general population.
Diabetes Care. 2008 Dec;31(12):2368-73. doi: 10.2337/dc08-0175. Epub 2008 Oct 3.
5
Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension.
Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1522-8. doi: 10.1152/ajpheart.00596.2008. Epub 2008 Aug 8.
7
Cardiovascular disease and modifiable cardiometabolic risk factors.
Clin Cornerstone. 2007;8(3):11-28. doi: 10.1016/s1098-3597(07)80025-1.
8
Insulin resistance and impaired functional vasodilation in obese Zucker rats.
Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1658-66. doi: 10.1152/ajpheart.01206.2007. Epub 2008 Feb 22.
9
Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension.
Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1840-50. doi: 10.1152/ajpheart.00692.2007. Epub 2008 Feb 1.
10
Alpha-adrenoceptor-mediated vasoconstriction is not involved in impaired functional vasodilation in the obese Zucker rat.
Clin Exp Pharmacol Physiol. 2008 May;35(5-6):611-6. doi: 10.1111/j.1440-1681.2007.04849.x. Epub 2007 Dec 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验